Clinical Trials · NCT06298799
GENETIC VARIABILITY TO GLP1 TREATMENT
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- GENGE
- Enrollment
- 400
- Start date
- Oct 2023
- Locations
- 1 site, Israel
- Primary endpoint
- Genetic variants and miRNA expressions associated with changes in BMI.